Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
QLGNCompany Name
QUALIGEN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQQUALIGEN THERAPEUTICS INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
QLGN - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 0 | 0% | $ 0 |
| 3/31/2025 | $ 0 | 0% | $ 0 |
| 12/31/2024 | $ 0 | 0% | $ 0 |
| 9/30/2024 | $ 4.5K | 0% | $ 0 |
| 6/30/2024 | $ -234.59K | 0% | $ 0 |
| 3/31/2024 | $ -111.81K | -6.87% | $ 1.63M |
| 12/31/2023 | $ 4.5K | 0% | $ 0 |
| 9/30/2023 | $ 109.99K | 2.38% | $ 4.62M |
| 6/30/2023 | $ 438.63K | 7.23% | $ 6.07M |
| 3/31/2023 | $ 407.66K | 6.95% | $ 5.87M |
Key Performance Insights, Last 5 Years
- QUALIGEN THERAPEUTICS INC's latest trailing twelve months (TTM) DepAmor % stands at 12.59%.
- Over the past 5 years, QUALIGEN THERAPEUTICS INC's average DepAmor % has been 5.93%.
- The median DepAmor % for QUALIGEN THERAPEUTICS INC during this period was 6.89%
- QUALIGEN THERAPEUTICS INC reached its highest DepAmor % over the past 5 years at 12.59%.
- The lowest DepAmor % recorded by QUALIGEN THERAPEUTICS INC in the same timeframe -6.87%
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for QUALIGEN THERAPEUTICS INC is calculated as follows: DepAmor [ $ 219.22K ] / Revenues [ $ 1.74M ]
(=) DepAmor % [ 12.59% ] QLGN - Depreciation and Amortization Margin, Last 5 years
-6.87%
Minimum
Mar 31, 2024
12.59%
Maximum
Sep 30, 2020
5.93%
Average
6.89%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.85% with a standard deviation of 5.12%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.31K |
|---|---|
| min | -6.41% |
| max | 22.52% |
| average | 5.85% |
| median | 4.22% |
| std | 5.12% |